| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Leukemia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Burkitt Lymphoma | |||||
| Leukemia, Lymphoid | |||||
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | |||||
| 3 | More general conditions related to this trial | ||||
| DNA Virus Infections | |||||
| Epstein-Barr Virus Infections | |||||
| Herpesviridae Infections | |||||
| Immune System Diseases | |||||
| Immunoproliferative Disorders | |||||
| Lymphatic Diseases | |||||
| Lymphoma | |||||
| Lymphoma, B-Cell | |||||
| Lymphoma, Non-Hodgkin | |||||
| Lymphoproliferative Disorders | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Experimental | |||||
| Tumor Virus Infections | |||||
| Virus Diseases | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Immunotoxins | |||||
| 5 | More general drug interventions related to this trial | ||||
| Immunologic Factors | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 6 | Sponsors listed in this trial | ||||
| Albert Einstein College of Medicine of Yeshiva University | |||||
|
